Why precision medicines for oncology demands precision engagement
MedCity News | May 24, 2019
Life sciences companies overwhelmed with large volumes of information and data available – both in terms of therapies and patient-reported outcomes – must establish a more efficient, bi-directional communication model with care teams to succeed.
Read more ›
Survey: Patient influencers trust social media more than pharma websites
MM&M | April 16, 2019
Patient influencers trust social media groups more than pharma websites for health information, according to a survey from Wego Health.
Read more ›
Walking the walk: How pharma companies can deliver patient-centric experiences
BIOPHARMADIVE | April 16, 2019
What does it mean to walk the walk and, more importantly, how can organizations ensure that a focus on patient centricity not only benefits patients but also drives business success?
Read more ›
In R&D, small biotechs hold their own against big pharma
BIOPHARMADIVE | April 23, 2019
Emerging biopharma companies patented almost two-thirds of new drugs in 2018, while large pharma patented one-quarter
Read more ›
A rough guide to…advisory boards
PMLive | March 23, 2016
Our intrepid writers take us on a journey through advisory boards and show that pre-trip planning is the pathway to perfection
Read more ›
Nine Key Elements to Ensure Advisory Board Success
PM360 | June 17, 2014
The relationship between pharmaceutical companies and medical stakeholders will need to evolve thanks to the greater public scrutiny these relationships will now receive under various regulatory changes including the Sunshine Act.
Pharma Medical Affairs: 2020 and Beyond
McKinsey & Company | 2014
Pharma’s Medical Affairs faces growing internal and external challenges as
well as new opportunities
Pharmaceutical companies should focus on medication adherence to improve revenue
Healthcare Finance Network | June 14, 2018
A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase their sales growth and margin profile.
Doctors and pharmaceutical companies work together to improve patient care-not pad pockets | Opinion
Penn Live | August 22, 2018
In recent years there has been a push towards more transparency regarding the financial relationship between physicians and pharmaceutical companies.
An Unwarranted Attack on Rare Disease Research
Forbes | August 28, 2018
Is the FDA really “less fussy about the kind of data that it requires for approval of a new drug for a rare disease“?